Literature DB >> 2715331

Serum immunoglobulin G antibody subclass response to respiratory syncytial virus F and G glycoproteins after first, second, and third infections.

D K Wagner1, P Muelenaer, F W Henderson, M H Snyder, C B Reimer, E E Walsh, L J Anderson, D L Nelson, B R Murphy.   

Abstract

Serum samples from 31 children who experienced two or three infections with respiratory syncytial virus (RSV) in the first four years of life were tested in an enzyme-linked immunosorbent assay to examine the immunoglobulin G (IgG) subclass responses to the RSV F and G surface glycoproteins associated with primary infection and reinfection. We sought to determine whether the greater degree of glycosylation of the G glycoprotein was reflected in an IgG subclass immune response more like that to a polysaccharide antigen than to a protein antigen. We found that the IgG1/IgG2 ratio of postinfection antibody titers to F was fourfold higher than that to the G glycoprotein after RSV infections 1, 2, and 3. The IgG2 response to the heavily glycosylated G glycoprotein differed from that to a polysaccharide antigen in that the IgG1/IgG2 ratio remained constant with age, whereas the response to a polysaccharide antigen decreased as the IgG2 response increased with age. We also noted that antibody responses to both surface glycoproteins in the IgG1 and IgG2 subclasses reached their maximum levels after RSV infection 2.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2715331      PMCID: PMC267370          DOI: 10.1128/jcm.27.3.589-592.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies.

Authors:  L J Anderson; J C Hierholzer; C Tsou; R M Hendry; B F Fernie; Y Stone; K McIntosh
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

Review 2.  Biological activities of immunoglobulins of different classes and subclasses.

Authors:  H L Spiegelberg
Journal:  Adv Immunol       Date:  1974       Impact factor: 3.543

3.  Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies.

Authors:  J B Robbins; J C Parke; R Schneerson; J K Whisnant
Journal:  Pediatr Res       Date:  1973-03       Impact factor: 3.756

4.  Nucleotide sequence of the gene encoding the fusion (F) glycoprotein of human respiratory syncytial virus.

Authors:  P L Collins; Y T Huang; G W Wertz
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

5.  Detection by ELISA of IgG-subclass-specific antibodies in primary respiratory syncytial (RS) virus infections.

Authors:  A Hornsleth; N Bech-Thomsen; B Friis
Journal:  J Med Virol       Date:  1985-08       Impact factor: 2.327

6.  Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children.

Authors:  F W Henderson; A M Collier; W A Clyde; F W Denny
Journal:  N Engl J Med       Date:  1979-03-08       Impact factor: 91.245

7.  Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity.

Authors:  P R Johnson; R A Olmsted; G A Prince; B R Murphy; D W Alling; E E Walsh; P L Collins
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

8.  Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein.

Authors:  G W Wertz; P L Collins; Y Huang; C Gruber; S Levine; L A Ball
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

9.  Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection.

Authors:  B R Murphy; B S Graham; G A Prince; E E Walsh; R M Chanock; D T Karzon; P F Wright
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

10.  Pneumococcal antibodies of different immunoglobulin subclasses in normal and IgG subclass deficient individuals of various ages.

Authors:  B Rynnel-Dagöö; A Freijd; L Hammarström; V Oxelius; M A Persson; C I Smith
Journal:  Acta Otolaryngol       Date:  1986 Jan-Feb       Impact factor: 1.494

View more
  19 in total

Review 1.  Immunity to human and bovine respiratory syncytial virus.

Authors:  T G Kimman; F Westenbrink
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

2.  Antibody responses against the G and F proteins of bovine respiratory syncytial virus after experimental and natural infections.

Authors:  R S Schrijver; J P Langedijk; W H van der Poel; W G Middel; J A Kramps; J T van Oirschot
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

3.  Structure and cell surface maturation of the attachment glycoprotein of human respiratory syncytial virus in a cell line deficient in O glycosylation.

Authors:  G W Wertz; M Krieger; L A Ball
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

4.  High frequency of repeated infections due to emerging genotypes of human respiratory syncytial viruses among children during eight successive epidemic seasons in Japan.

Authors:  Masahiro Yamaguchi; Yasuko Sano; Isolde C Dapat; Reiko Saito; Yasushi Suzuki; Akihiko Kumaki; Yugo Shobugawa; Clyde Dapat; Makoto Uchiyama; Hiroshi Suzuki
Journal:  J Clin Microbiol       Date:  2010-12-22       Impact factor: 5.948

5.  CD4(+) T-cell-mediated antiviral protection of the upper respiratory tract in BALB/c mice following parenteral immunization with a recombinant respiratory syncytial virus G protein fragment.

Authors:  H Plotnicky-Gilquin; A Robert; L Chevalet; J F Haeuw; A Beck; J Y Bonnefoy; C Brandt; C A Siegrist; T N Nguyen; U F Power
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

6.  Inability to evoke a long-lasting protective immune response to respiratory syncytial virus infection in mice correlates with ineffective nasal antibody responses.

Authors:  Richard Singleton; Nathalie Etchart; Sam Hou; Lisa Hyland
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

7.  Sin nombre virus (SNV) Ig isotype antibody response during acute and convalescent phases of hantavirus pulmonary syndrome.

Authors:  P Bostik; J Winter; T G Ksiazek; P E Rollin; F Villinger; S R Zaki; C J Peters; A A Ansari
Journal:  Emerg Infect Dis       Date:  2000 Mar-Apr       Impact factor: 6.883

8.  Monoclonal antibody-based capture enzyme immunoassays for specific serum immunoglobulin G (IgG), IgA, and IgM antibodies to respiratory syncytial virus.

Authors:  D D Erdman; L J Anderson
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

9.  Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primates.

Authors:  John T Bates; Jennifer A Pickens; Jennifer E Schuster; Monika Johnson; Sharon J Tollefson; John V Williams; Nancy L Davis; Robert E Johnston; Nancy Schultz-Darken; James C Slaughter; Frances Smith-House; James E Crowe
Journal:  Vaccine       Date:  2016-01-07       Impact factor: 3.641

10.  A viral-vectored RSV vaccine induces long-lived humoral immunity in cotton rats.

Authors:  Jessica L Grieves; Zhiwei Yin; Adolfo Garcia-Sastre; Ignacio Mena; Mark E Peeples; Heidi P Risman; Hannah Federman; Marvin J Sandoval; Russell K Durbin; Joan E Durbin
Journal:  Vaccine       Date:  2018-05-18       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.